The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH MM 2018 | Where will we be in MM management 5 years from now?
Elena Zamagni, MD, PhD, of the University of Bologna, Bologna, Italy, discusses the future landscape of multiple myeloma (MM) management at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France. With excellent diagnostic and analytical tools available for examining the bone marrow and beyond, Dr Zamagni believes we are well on the way to personalized treatment for MM. She highlights the increasing success of treatment and measurable residual disease measurement for MM patients in reaching complete remission.
